2.18
The acute complications of diabetes mellitus include the following.
Diabetic ketoacidosis, or DKA, is more common in type 1 diabetes but can also develop in type 2 diabetes during periods of severe relative insulin deficiency in the setting of metabolic stress such as infection. It presents with hyperglycemia, ketonemia, and metabolic acidosis.
The hyperosmolar hyperglycemic state, or HHS, primarily develops in type 2 diabetes and is characterized by severe hyperglycemia, high plasma osmolality, and minimal or absent ketosis.
Hypoglycemia is a complication of diabetes treatment, especially with insulin or insulin secretagogues.
Over time, sustained hyperglycemia increases the risk of infection, delays wound healing, and damages the vascular system.
Macrovascular complications affect large blood vessels and increase the risk of coronary and peripheral artery disease and stroke.
Microvascular complications include retinopathy, nephropathy, and neuropathy.
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.
Acute Complications
Acute complications result from sudden metabolic imbalance.
Chronic Complications
Chronic complications develop from prolonged hyperglycemia.
Other Complications
Neuropathy and vascular disease predispose to foot ulcers, infections, and amputations. Skin changes include diabetic dermopathy and acanthosis nigricans. Hyperglycemia also impairs immunity, increasing the risk of infections (UTIs, candidiasis) and delaying wound healing.
The acute complications of diabetes mellitus include the following.
Diabetic ketoacidosis, or DKA, is more common in type 1 diabetes but can also develop in type 2 diabetes during periods of severe relative insulin deficiency in the setting of metabolic stress such as infection. It presents with hyperglycemia, ketonemia, and metabolic acidosis.
The hyperosmolar hyperglycemic state, or HHS, primarily develops in type 2 diabetes and is characterized by severe hyperglycemia, high plasma osmolality, and minimal or absent ketosis.
Hypoglycemia is a complication of diabetes treatment, especially with insulin or insulin secretagogues.
Over time, sustained hyperglycemia increases the risk of infection, delays wound healing, and damages the vascular system.
Macrovascular complications affect large blood vessels and increase the risk of coronary and peripheral artery disease and stroke.
Microvascular complications include retinopathy, nephropathy, and neuropathy.
From Chapter 2:
Now Playing
Endocrine Disorders
110 Views
Endocrine Disorders
1.1K Views
Endocrine Disorders
518 Views
Endocrine Disorders
197 Views
Endocrine Disorders
187 Views
Endocrine Disorders
148 Views
Endocrine Disorders
177 Views
Endocrine Disorders
148 Views
Endocrine Disorders
185 Views
Endocrine Disorders
196 Views
Endocrine Disorders
170 Views
Endocrine Disorders
229 Views
Endocrine Disorders
181 Views
Endocrine Disorders
227 Views
Endocrine Disorders
138 Views
See More